Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0EH2O
|
|||
Former ID |
DIB013117
|
|||
Drug Name |
BIMG80
|
|||
Indication | Psychotic disorder [ICD-11: 6A20-6A25] | Terminated | [1] | |
Company |
Boehringer Ingelheim Corp
|
|||
Structure |
Download2D MOL |
|||
Formula |
C25H27FN2O2
|
|||
Canonical SMILES |
COC1=CC2=C(C=C1)NC=C2CC3=CCCN(C3)CCCC(=O)C4=CC=C(C=C4)F
|
|||
InChI |
1S/C25H27FN2O2/c1-30-22-10-11-24-23(15-22)20(16-27-24)14-18-4-2-12-28(17-18)13-3-5-25(29)19-6-8-21(26)9-7-19/h4,6-11,15-16,27H,2-3,5,12-14,17H2,1H3
|
|||
InChIKey |
CIPFPNCFILKTBF-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006596) | |||
REF 2 | BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex. J Neurochem. 1997 Jul;69(1):182-90. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.